Skip to Main Content
Try STAT+ TODAY
Trending:
The Obesity Revolution
STAT+
Health
Biotech
Subscribe Now To access exclusive content, subscribe to STAT+
View Latest View the latest STAT+ stories
Biotech
STAT+

‘A huge win for biology’: Trial shows anti-inflammatory drugs may reduce heart disease

  • Meghana Keshavan

By Meghana Keshavan June 27, 2017

Reprints
Heart Research
Jean-Sebastien Evrard/AFP/Getty Images

Could we see an explosion of new anti-inflammatory therapies for heart disease?

Perhaps. That’s because Novartis may have just helped validate a long-standing theory: That targeting inflammation could play critical role in reducing the incidence of heart disease.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED

About the Author Reprints

Meghana Keshavan

Meghana Keshavan

Biotech Correspondent

Meghana Keshavan covers biotech and contributes to The Readout newsletter.

Tags

Researchers devise new strategies to overcome a key CRISPR…
Researchers devise new strategies to overcome a key CRISPR flaw
Cerebral and other telehealth startups face new legal and…
Cerebral and other telehealth startups face new legal and regulatory challenges over ad models
Experts weigh in on potential health hazards posed by…
Experts weigh in on potential health hazards posed by chemicals in Ohio train derailment
FDA advisory panel recommends conditional approval of Biogen’s drug…
FDA advisory panel recommends conditional approval of Biogen’s drug for rare form of ALS
Social media is part of a ‘self-perpetuating cycle of…
Social media is part of a ‘self-perpetuating cycle of risk’ for eating disorders and negative body…
The lesson biotech absolutely should not take from Silicon…
The lesson biotech absolutely should not take from Silicon Valley Bank’s failure

Comments are closed.

Recommended Stories